ATLASKiora Pharmaceuticals (KPRX) earnings date: Nov 6, 2026
Kiora Pharmaceuticals (KPRX) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on KPRX
| Last price | $1.56 (-11.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.7% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Kiora Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Kiora Pharmaceuticals reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Kiora Pharmaceuticals. You can switch it off at any time.
Alert me before KPRX reportsFree to start. Creating an account takes under a minute.
Notify me when Kiora Pharmaceuticals reports
KPRX earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Oct 15, 2026 · In line |
| Beat rate (last 6 reports) | 3 of 6 (50%) |
| Average EPS surprise | +3.3% |
| Average move around a report | ±2.0% (last 6) |
| Sector | Healthcare · Biotechnology |
Kiora Pharmaceuticals earnings history: last 6 reports
Kiora Pharmaceuticals last reported on Oct 15, 2026: EPS of $4.60 against an estimate of $4.52 (+1.8% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 15, 2026 | $4.52 | $4.60 | +1.8% | In line | -2.8% |
| Aug 7, 2026 | -$0.62 | -$0.34 | +45.2% | Beat | +0.8% |
| May 8, 2026 | -$0.71 | -$0.58 | +18.3% | Beat | -1.6% |
| Mar 25, 2026 | -$0.67 | -$1.56 | -132.8% | Miss | -4.4% |
| Jan 30, 2026 | $0.42 | $0.36 | -14.3% | Miss | +1.7% |
| Nov 7, 2025 | -$0.72 | $0.01 | +101.4% | Beat | +0.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for KPRX
See the fair value, the probability range and the earnings history of Kiora Pharmaceuticals on its ATLAS page.
Kiora Pharmaceuticals (KPRX) stock analysisPlans from €3.99 a month.
Kiora Pharmaceuticals earnings: frequently asked questions
When does Kiora Pharmaceuticals (KPRX) report earnings?
Kiora Pharmaceuticals is scheduled to report on Friday, November 6, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does KPRX beat earnings estimates?
Of its last 6 reports with a recorded result, Kiora Pharmaceuticals beat the EPS estimate 3 times; the average surprise was +3.3%. Past results do not predict the next one.
How much does KPRX move around earnings?
Over its last 6 reports the stock moved an average of 2.0% (absolute, from the close before the report day to the close after it), and finished higher 3 of 6 times.
Did Kiora Pharmaceuticals beat earnings estimates last quarter?
Kiora Pharmaceuticals last reported on Oct 15, 2026: EPS of $4.60 against an estimate of $4.52 (+1.8% surprise), in line with the estimate.
How much does KPRX usually move in a day?
On a normal trading day the ATLAS model puts KPRX’s one-day range at about ±6.7%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer